Showing results (131-140 of 679) with videos related to

Sort By:
Pageof 68
Pharmacological Research|November 26, 2016
Deacetylase inhibitors as a novel modality in the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Cytotherapy|June 5, 2013
Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor aloneBeatrice Gaugler, Jessy Arbez, Steven Legouill, et al.
ACS Applied Materials & Interfaces|September 12, 2022
Pristine Surface of Ni-Rich Layered Transition Metal Oxides as a Premise of Surface ReactivityAngelica Laurita, Liang Zhu, Pierre-Etienne Cabelguen, et al.
Haematologica|September 5, 2008
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myelomaPhilippe Moreau, Valerie Coiteux, Cyrille Hulin, et al.
Expert Review of Clinical Pharmacology|October 28, 2015
Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomesPaul G Richardson, R Donald Harvey, Jacob P Laubach, et al.
Nature Communications|January 4, 2019
Acto-myosin force organization modulates centriole separation and PLK4 recruitment to ensure centriole fidelityElisa Vitiello, Philippe Moreau, Vanessa Nunes, et al.
Data in Brief|July 14, 2025
High temperature stress-strain data for SAE 5120 steel under various strain ratesPhilippe Moreau, Jean-Dominique Guérin, José Grégorio La Barbara Sosa, et al.
Immunology|July 20, 2019
The Autoimmune Regulator (Aire) transactivates HLA-G gene expression in thymic epithelial cellsBreno Luiz Melo-Lima, Isabelle Poras, Geraldo Aleixo Passos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2010
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS groupCaroline Bodet-Milin, Cyrille Touzeau, Christophe Leux, et al.
Blood|August 15, 2002
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyPhilippe Moreau, Thierry Facon, Xavier Leleu, et al.
Pageof 68